Medigus (TASE:MDGS) completed a public issuance of shares and options in the total amount of NIS 24.8 million

on .

Omer, Israel - October 21, 2013

Medigus Ltd (TASE: MDGS) is pleased to announce that it completed a public issuance of shares and options on Thursday, October 17, 2013, in the total amount of NIS 24.8 million (approximately $7 million). During the issuance, which was held pursuant to the company's shelf prospectus, the company issued approximately 34.5 million shares at NIS 0.72 per share, constituting approximately 21% of the present voting rights in the company, together with approximately 17.3 million options with an exercise price of NIS 1.08 with a 3-year exercise period. OrbiMed Israel as well as US investment funds took part in the offering. The company is grateful to its investors for their participation in the shelf offer.

logo blue



Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE™ System, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam™ 1.2, which to the best of the company's knowledge, is the smallest in the world.
Read more

News & Events